Similar to Changes Being Effected (CBE). A filing with the FDA to gain approval of a moderate change, i.e., a change that has a moderate potential to have an adverse effect on the identity, strength, quality, purity, or potency of the drug product as… Read More »
A filing with the FDA to gain approval of a major change that has a substantial potential to have an adverse effect on the identity, strength, quality, purity, or potency of a drug product as these factors may relate to the safety or effectiveness of… Read More »
Michael Troullis has been named chief financial officer, Quintiles Transnational Corp., effective immediately. Mr. Troullis had been acting chief financial officer for the past year. He will report to Dennis Gillings, CBE, chairman and chief executiv… Read More »
Dennis Gillings, CBE, chairman and chief executive officer of Quintiles Transnational Corp., dedicated a new facility in Overland Park, KS, with Secretary David Kerr of the Kansas Department of Commerce.
The 236,000-sq.-ft. building will house Qu… Read More »
Solvay Pharmaceuticals has renewed its clinical development alliance with Quintiles Transnational Corp. for another five years. First signed in 2001, the renewal reflects the success in accelerating development of Solvay's product portfolio and impro… Read More »